Myelotoxic Chemotherapy Interactions

1 interaction on record

Do not administer palifermin within 24 hours before, during, or within 24 hours after myelotoxic chemotherapy. Administration within 24 hours resulted in increased severity and duration of oral mucositis.

Source: NLP:palifermin